Skip to content
healthcare.dev

Griseofulvin

NDC 0781-5515, Griseofulvin, tablet, from Sandoz Inc.

Product NDC
0781-5515
Status
Listed
Labeler
Sandoz Inc
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091592
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0781-5515 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GRISEOFULVIN500 mg/1

Pharmacologic classes

Decreased Mitosis [PE]; Microtubule Inhibition [PE]; Tubulin Inhibiting Agent [EPC]

Package NDCNDC-11Package
0781-5515-0100781551501100 TABLET in 1 BOTTLE (0781-5515-01)
0781-5515-0500781551505500 TABLET in 1 BOTTLE (0781-5515-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/98829d90-b289-4bec-a625-7af412a5cb2d
  • NADAC price for package 00781551501

    GET /v1/drugs/nadac/00781551501

Use it

Look up 0781-5515 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0781-5515 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0781-5515. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.